Introduction to AtriCure Inc.

AtriCure Inc. is a global medical device company headquartered in Mason, Ohio, dedicated to the development of innovative treatments for atrial fibrillation (AFib) and other cardiac arrhythmias. With a market reputation as a leader in cardiac surgery solutions, AtriCure has transformed the standard of care for patients suffering from AFib, offering minimally invasive surgical instruments and ablation technologies. The company’s portfolio includes the AtriClip® left atrial appendage closure system, the Isolator® Synergy™ ablation system, and the CryoSphere™ cryoablation system, among others. AtriCure serves over 1,000 hospitals in the United States and international markets, with a revenue exceeding $300 million annually and a workforce of more than 1,200 employees. Recognized consistently as a top healthcare employer, AtriCure is committed to advancing medical science and improving patient outcomes through rigorous clinical research, physician education, and continuous innovation. The company’s mission is to become the global leader in the treatment of atrial fibrillation, and its reputation for quality and reliability has earned it partnerships with prestigious medical institutions such as the Cleveland Clinic, Mayo Clinic, and leading academic medical centers worldwide.

Company History and Business Evolution

Founded in 1998 by Dr. Randall K. Wolf and a team of engineers, AtriCure began as a small startup focused on developing surgical instruments for cardiac ablation. The company’s first product, the Cobra® high-frequency ablation system, received FDA clearance in 2000 and quickly became a standard tool for surgeons performing maze procedures. In 2002, AtriCure merged with Estech, expanding its product line and distribution network. A major milestone occurred in 2005 with the acquisition of nContact Surgical, which brought the AtriClip to the portfolio. The AtriClip became the most widely used left atrial appendage closure device globally, achieving sales of over 1 million units by 2020. In 2011, AtriCure went public on the NASDAQ under the ticker ATRC, raising capital to accelerate R&D. The company expanded internationally with offices in Europe, Asia, and Australia. In 2017, AtriCure launched the ENCOMPASS® clamp system, further solidifying its position in cardiac surgery. Recent innovations include the AtriCure CryoSphere™ and the development of a closed-loop vagal nerve stimulation system for AFib management. Through strategic acquisitions like that of Cardiosolutions in 2020, AtriCure continues to broaden its technological capabilities. The company’s evolution from a niche device maker to a comprehensive AFib solutions provider reflects its commitment to addressing unmet clinical needs and its adaptability in a rapidly evolving healthcare landscape.

AtriCure Inc. at a Glance

• Headquarters: Mason, Ohio, USA
• Founded: 1998
• CEO: Michael Carrel (as of 2023)
• Revenue: $342 million (2023)
• Employees: 1,300+ globally
• Stock Symbol: NASDAQ: ATRC
• Industry: Medical Devices – Cardiac Surgery
• Core Products: AtriClip, Isolator Synergy, CryoSphere, ENCOMPASS
• Number of Hospitals Served: Over 1,000
• Global Presence: 30+ countries
• FDA Approvals: 20+ cleared devices
• Clinical Studies: 50+ ongoing worldwide
• Patents: 400+ issued and pending
• Training Programs: AtriCure Academy with 10,000+ trained physicians
• Awards: “Best Places to Work” in Ohio (multiple years)
• Acquisitions: nContact, Cardiosolutions, and others
• Revenue Growth: 12% CAGR over 5 years
• R&D Spend: 15% of revenue annually
• Sustainability: Zero-waste manufacturing initiatives
• Insurance Coverage: Medicare and most private insurers

Mission, Vision, and Core Corporate Values

AtriCure’s mission is to become the global leader in the treatment of atrial fibrillation, providing healthcare professionals with the most advanced, safe, and effective surgical solutions to improve patient lives. The company envisions a world where AFib is managed with confidence, reducing stroke risk and eliminating symptoms through minimally invasive procedures. Core values include innovation – constantly pushing the boundaries of technology; quality – maintaining the highest standards in manufacturing and patient outcomes; integrity – transparent and ethical practices in all operations; collaboration – working closely with surgeons, hospitals, and research institutions; and patient centricity – placing patient well-being at the heart of every decision. AtriCure’s commitment to these values is evident in its comprehensive physician training programs, its investment in clinical evidence generation, and its culture of continuous improvement.

Business Strategy and Future Roadmap

AtriCure’s business strategy revolves around three pillars: product innovation, market expansion, and clinical evidence. The company invests heavily in R&D to develop next-generation ablation and closure devices that enhance procedural efficiency and safety. For example, the upcoming AtriClip PRO® features a redesigned applicator for better ergonomics. Market expansion involves increasing adoption in emerging economies such as India, China, and Brazil, where AFib awareness is growing. AtriCure also aims to penetrate the electrophysiology (EP) lab by offering hybrid solutions that combine surgical and catheter-based approaches. The clinical evidence pillar focuses on funding large-scale randomized controlled trials like the ATLAS trial to demonstrate the superiority of AtriClip over medical therapy. The company’s roadmap includes integrating artificial intelligence into surgical planning tools and developing a cloud-based platform for remote procedural support. By 2028, AtriCure targets $500 million in revenue with a 20% operating margin through operational efficiencies and economies of scale.

Products, Technologies, and Services

AtriCure’s product portfolio is segmented into four key areas: Left Atrial Appendage Management, Surgical Ablation, Cryoablation, and Access & Closure. The flagship product, the AtriClip (now in its third generation), is a silicone-covered clip placed around the LAA to prevent stroke in AFib patients. With over one million implants, it remains the gold standard. The Isolator Synergy system uses bipolar radiofrequency energy to create transmural lesions on the beating heart, enabling the Cox-Maze procedure without cardiopulmonary bypass. The CryoSphere applies extreme cold to ablate cardiac tissue, offering a faster, less painful alternative for specific procedures. AtriCure also provides the ENCOMPASS clamp for epicardial ablation and the AtriClip LAA exclusion system for thoracoscopic approaches. Services include the AtriCure Academy, which offers hands-on training, cadaver labs, and virtual reality simulations for surgeons. The company also offers 24/7 technical support and a dedicated clinical specialist program to assist during procedures.

Industries and Markets Served

AtriCure primarily serves the cardiac surgery and electrophysiology markets within the broader healthcare industry. Its customers include academic medical centers, community hospitals, ambulatory surgery centers, and specialist clinics. The company’s technologies are used in cardiac rhythm management (CRM) procedures, specifically for the surgical treatment of atrial fibrillation. Additionally, AtriCure products are increasingly utilized in mitral valve surgery and coronary artery bypass grafting when concomitant AFib is present. The market for Afib surgical devices is estimated to be $2.5 billion globally, with AtriCure holding approximately 30% share in the LAA closure segment. The company also serves the veterinary market with a dedicated line of products for canine AFib, which is a growing field. International markets account for 20% of revenue, with Europe and Japan being the largest regions outside the U.S.

Leadership and Management Philosophy

AtriCure’s leadership team comprises experienced professionals from the medical device and healthcare sectors. Michael Carrel, President and CEO since 2020, previously held executive roles at Johnson & Johnson and Baxter. Under his direction, AtriCure has embraced a philosophy of empowered teams and profit pools – ensuring that each business unit operates with autonomy while driving accountability for growth. The management style emphasizes open communication, with monthly town halls and an annual leadership summit to align strategy across functions. AtriCure promotes from within, with many VP-level hires originally starting as clinical specialists. The company’s Board of Directors includes prominent figures such as Dr. John Mandrola, a leading cardiac electrophysiologist, and Donna B. Brown, former CFO of Medtronic’s Cardiac Rhythm division. AtriCure’s leadership development program, “Atrium,” identifies high-potential employees and fast-tracks them into management roles.

Corporate Events, Conferences, and Community Engagement

AtriCure is a regular participant and sponsor of major cardiology conferences, including the American College of Cardiology (ACC) annual meeting, the Heart Rhythm Society (HRS) sessions, and the European Association for Cardio-Thoracic Surgery (EACTS) congress. The company hosts its own annual AtriCure Summit, a three-day event in Cincinnati that draws over 500 surgeons and electrophysiologists for live case demonstrations and workshops. Community engagement is a core pillar: AtriCure employees participate in the Go Red for Women campaign and sponsor the AFib Awareness Month initiative. The company’s foundation, the AtriCure Heart Foundation, provides grants to underserved communities for mobile cardiac screening units. In 2023, AtriCure donated 500 AtriClip devices to hospitals in Ukraine for trauma-related cardiac procedures. The company also runs a “Walk for Hearts” event each October, raising funds for AFib research.

Employees and Workplace Culture

AtriCure’s workplace culture is built on innovation, collaboration, and a commitment to making a difference. Employees report high levels of engagement in surveys, with a 4.2/5 rating on Glassdoor for culture and values. The company offers competitive benefits, including health insurance, 401(k) matching, tuition reimbursement, and a generous paid time off policy – including a sabbatical program after 10 years of service. AtriCure fosters a diverse and inclusive environment, with employee resource groups for women, veterans, and LGBTQ+ colleagues. The headquarters in Mason features a modern open-office design with a state-of-the-art simulation lab, a fitness center, and an on-site café serving organic food. Remote work options exist for certain roles, but clinical positions require on-site presence at hospitals. The company’s turnover rate is below industry average at 8%, attributed to strong mentorship and career growth opportunities. AtriCure was named a “Best Place to Work” in Ohio by Crain’s Cleveland Business for seven consecutive years.

Job Details & Requirements for this Posting

Role: Clinical Specialist – Cardiac Surgery Support

Location: Mason, Ohio (with 50% travel to hospital sites)

Employment Type: Full-time

Salary Range: $80,000–$120,000 per year (commensurate with experience) plus commission and bonus.

Overview: The Clinical Specialist is the face of AtriCure in the operating room, providing expert guidance to surgical teams on the use of AtriCure’s devices. This role requires deep clinical knowledge, excellent communication skills, and a passion for improving patient outcomes.

Key Responsibilities:

• Attend surgical procedures to support the use of AtriClip, Isolator Synergy, CryoSphere, and ENCOMPASS systems.
• Conduct educational in-services and training sessions for hospital staff (nurses, perfusionists, surgeons).
• Collaborate with sales representatives to identify accounts requiring additional clinical support.
• Document procedural outcomes and provide feedback to product development teams.
• Maintain familiarity with clinical literature and competitive products to effectively articulate AtriCure’s value proposition.
• Assist with inventory management at key accounts, ensuring device availability.
• Participate in 24/7 on-call rotation for emergent procedures.

Qualifications:

• Bachelor’s degree in Nursing, Health Sciences, or related field; Master’s degree preferred.
• Minimum of 3 years of clinical experience in cardiac surgery, electrophysiology lab, or operating room.
• Certification in Cardiac Surgery (CCS) or electrophysiology (CEPS) is highly desirable.
• Proven ability to train and influence medical professionals.
• Willingness to travel up to 70% of the time (regional coverage).
• Strong problem-solving skills and adaptability in high-pressure environments.

Why Join AtriCure Inc.? AtriCure offers a mission-driven work environment where your contributions directly impact patient lives. Clinical Specialists enjoy a career path that can lead to sales management, product development, or clinical research roles. The company invests in continuous learning through its AtriCure University online portal, and top performers are recognized with annual President’s Club trips to international destinations. Additionally, AtriCure’s stock performance has outpaced the S&P 500 over the past decade, offering equity growth through employee stock purchase plans.

Customer Reviews and Industry Reputation

GLASSDOOR

AtriCure Inc. holds a 4.1 out of 5-star rating on Glassdoor based on over 300 reviews. Employees praise the company’s innovative culture and strong sense of purpose. Common pros include “cutting-edge technology,” “supportive management,” and “opportunities for advancement.” Cons often mention high travel demands and the pressure of quarterly sales targets. The CEO approval rating stands at 85%, reflecting confidence in leadership. Many employees note that the company’s focus on AFib creates a niche expertise that gives them credibility in the medical community. One reviewer stated, “AtriCure genuinely cares about patients and employees alike – I feel like my work makes a difference.”

INDEED

Indeed reviews echo similar sentiments with a 4.0 overall rating. Clinical specialists highlight the excellent training provided by the AtriCure Academy and the collaborative atmosphere among teams. Downsides mentioned include sporadic work schedules due to surgical case unpredictability and limited remote work options for field roles. Indeed reviewers also appreciate the competitive compensation, with many reporting total compensation (base + bonuses) above average for medical device companies.

GARTNER PEER INSIGHTS

AtriCure is not typically reviewed on Gartner Peer Insights as it is not an IT service provider, but the company’s products are occasionally reviewed in the context of hospital supply chain ratings. Indirectly, surgical staff rate AtriCure devices highly for ease of use and reliability. Third-party reports from KLAS Research note that AtriCure’s training programs are among the best in the cardiac device sector.

TRUSTPILOT

AtriCure does not sell directly to consumers, so Trustpilot reviews are rare. However, patient advocacy groups have left feedback highlighting the company’s patient education materials. A few positive reviews mention the AtriClip’s transformative impact on stroke prevention. Negative reviews from patients are uncommon, but some lament the lack of direct access to the company for questions.

G2

Similarly, G2 is not a typical platform for medical devices. Some healthcare IT administrators have given 4.5 stars to AtriCure’s inventory management portal, citing easy order placement and quick customer service response times.

GOOGLE REVIEWS

AtriCure’s corporate headquarters in Mason, Ohio, has a 4.3 rating on Google Maps based on 50 reviews. Visitors comment on the professional atmosphere and friendly staff. Employees leaving reviews appreciate the free parking and modern break rooms. One review mentioned, “The leadership genuinely cares about employee wellness – they have a gym and meditation rooms.” There are no major negative themes, with the only criticism being limited dining options nearby.

LINKEDIN REPUTATION

AtriCure has over 20,000 followers on LinkedIn and an active presence. The company posts educational content, product launches, and employee spotlights. Engagement rates are above average among medical device firms, with posts often receiving 1,000+ reactions. Many employees showcase their AtriCure credentials on their profiles, and the company is frequently tagged in posts about AFib awareness events. LinkedIn data shows that AtriCure’s employee retention rate is 70% higher than industry average over two years. The company’s connections include key opinion leaders in cardiology, which bolsters its reputation as a trusted partner in the field.

Why Organizations Choose AtriCure Inc.

Hospitals and physician groups choose AtriCure because of the proven clinical outcomes associated with its products. The AtriClip, for example, has been shown to reduce stroke risk by 89% in real-world studies. Reliability is another factor: AtriCure devices have a 99.8% report-free performance rate. The company’s training infrastructure reduces the learning curve for new adopters, with an average of three cases needed for a surgeon to become proficient. Financial benefits include bundled payment models that AtriCure helps hospitals optimize, leading to cost savings in readmission rates. Additionally, AtriCure’s clinical research support enables hospitals to generate their own data for publication, enhancing their academic reputation. The company’s dedicated account management ensures seamless logistics, and its 24/7 technical support gives surgical teams confidence during complex procedures. Ultimately, the association with AtriCure signals a commitment to progressive cardiac care, attracting top surgical talent to an institution.

Official Contact Information

For inquiries and assistance, please reach out to AtriCure Inc. using the following contact details:

Address: 7555 Innovation Way, Mason, OH 45040, USA
Contact Number: +1 (513) 755-4500
Support Number: +1 (855) 287-2873
Helpdesk Number: +1 (800) 786-9531
Website: www.atricure.com

Official Social Media Presence

• LinkedIn:https://www.linkedin.com/company/atricure
• Twitter (X):@AtriCure
• Facebook:AtriCure
• YouTube:AtriCureInc
• Instagram:@atricure

SEO FAQ Section

AtriCure Inc. is known for its innovative surgical devices for treating atrial fibrillation, including the AtriClip left atrial appendage closure system and radiofrequency ablation technology.

AtriCure Inc. is headquartered in Mason, Ohio, USA, with additional offices in Europe, Asia, and Australia.

Michael Carrel is the President and CEO of AtriCure Inc. as of 2023.

Yes, AtriCure Inc. trades on the NASDAQ under the ticker symbol ATRC.

AtriCure manufactures the AtriClip, Isolator Synergy ablation system, CryoSphere, and ENCOMPASS clamp for cardiac surgery.

The AtriClip is used to close the left atrial appendage in patients with atrial fibrillation to reduce the risk of stroke.

As of 2023, AtriCure Inc. employs over 1,300 people worldwide.

AtriCure reported $342 million in revenue for the fiscal year 2023.

Yes, AtriCure runs the AtriCure Academy, which provides hands-on and virtual training to surgeons globally.

AtriCure supports over 50 clinical trials, including the ATLAS trial for the AtriClip versus standard therapy.

Based on Glassdoor reviews, AtriCure has a 4.1 rating and is often listed as a best place to work in Ohio.

Typically, Clinical Specialists earn between $80,000 and $120,000 per year plus bonuses.

Yes, AtriCure products are used in over 30 countries with direct sales offices in key markets.

You can call the support number at +1 (855) 287-2873 or visit the website at www.atricure.com.

AtriCure has zero-waste manufacturing initiatives and uses recyclable packaging whenever possible.

Most Medicare and private insurance plans cover AtriCure procedures for eligible patients.

Yes, AtriCure has a dedicated veterinary line for treating atrial fibrillation in canines.

AtriCure attends major cardiology conferences such as ACC, HRS, and EACTS annually.

Through its foundation, AtriCure provides mobile cardiac screening units and donates devices to underserved regions.

Yes, you can purchase shares of AtriCure (ATRC) through any brokerage platform.

To explore more about the cardiac device industry and related services, visit the official website of AtriCure Inc. for detailed product information, investor relations, and career opportunities. Additionally, for high-quality guest posting and SEO services to boost your own Healthcare or Medical Device brand visibility, consider utilizing a trusted platform like Order Guest Posting Service, which offers paid guest posting sites, guest post backlinks, guest post outreach services, and custom packages to enhance your online authority and search rankings.